Financial Releases

Raffles Medical Group's fiscal year-end is 31 December.

With effect from 7 Feb 2020, the Company has decided to adopt the announcement of half-yearly financial statements with effect from the financial year ending 31 December 2020 (FY2020).

Click here to view or download our Income Statements dating back to year 2005.

Click here to view or download our Annual Reports dating back to year 2000.

Raffles Medical Group Stock Information

Raffles Medical Group shares are traded in Singapore on the Mainboard of SGX-ST.

Raffles Medical Group shares can be bought over-the-counter on the Singapore Exchange. Trading of Raffles Medical Group shares in Singapore is scripless, and can be bought through any local securities firm. The minimum trading size for the stock is 100 shares.

Raffles Medical Group was Listed on 11 April 1997 on SGX Sesdaq and 10 July 2000 on SGX Mainboard. The share price at the IPO was S$0.38.

In May 2007, the Company offered a one-for-ten Bonus issue.
In May 2016, the Company offered a three-for-one ​Share split.

The dividend paid for Raffles Medical Group's shares in the past ten financial years is as follows:

  • FY 2019^ : 2.25 cents / share
  • FY 2018   : 2.25 cents / share
  • FY 2017   : 2.25 cents / share
  • FY 2016   : 2.00 cents / share
  • FY 2015* : ​2.00 cents / share
  • FY 2014* : ​1.83 cents / share 
  • FY 2013* : ​1.67 cents / share
  • FY 2012* : ​1.50 cents / share
  • FY 2011* : ​1.33 cents / share
  • FY 2010* : 1.17 cents / share

*Dividend figure adjusted to reflect effect from the three-for-one share split in 2016.
^Interim dividend of 0.5 cents/share paid in August 2019 and a recommended final dividend of 2.0 cents/share subject to shareholders approval at the next Annual General Meeting.

Reuters: RAFG.SI
Bloomberg: RFMD:SP

Raffles Medical Group’s share price information is available on the Singapore Exchange's website, www.sgx.com.

No. Raffles Medical Group shares can only be purchased through a licensed stockbroker.

Please click here for a list of securities houses / research analysts covering the Raffles Medical Group stock.